Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb). 2025-01-11 17:07
Corn Next Launches CornNext-17: A Groundbreaking Sustainable Solution to Plastic Pollution 2025-01-11 05:53
JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in China as Second-line Treatment in Relapsed or Refractory adult Large B-cell Lymphoma 2025-01-10 17:00
UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform 2025-01-09 16:41
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development 2025-01-09 09:45
DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu 2025-01-09 03:48
Latest Updates of Viva Biotech's Portfolio Companies 2025-01-08 20:19
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report 2025-01-08 16:12
Verismo Therapeutics Announces Strategic Partnership with IFLI to Support SynKIR™-310 Development in Follicular Lymphoma 2025-01-07 21:00
Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment 2025-01-07 20:14
Innovent to Participate and Present at the 43rd Annual J.P. Morgan Healthcare Conference 2025-01-06 08:00
Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration 2025-01-03 08:00
Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate 2025-01-02 07:30
Brii Bio Announces Signing of Asset Purchase Agreements Acquiring BRII-179 IP Rights and Completed Patient Enrollment for ENRICH Study 2024-12-31 19:10
Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer 2024-12-30 13:28
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging 2024-12-30 06:00
Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference 2024-12-27 09:44
IND Application for a Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Approved 2024-12-26 17:09
New Generation Centralized Control System Promotes "Integrated Operation Monitoring" 2024-12-26 13:38
Industry Partnership | Basecare Medical Group (2170.HK) and Jinghua Medical Group Sign Strategic Cooperation Agreement 2024-12-25 11:03
1 2 3 4 5 234